Immunoglobulin, nucleos(t)ide analogues and hepatitis B virus recurrence after liver transplant: A meta‐analysis

BACKGROUND: Prophylaxis with hepatitis B immunoglobulin (HBIG) represents an efficient strategy for reducing the risk of hepatitis B virus (HBV) recurrence after liver transplantation (LT). Unfortunately, the long‐term use of HBIG presents high costs. Therefore, the use of prophylaxis based only on...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Quirino, Mennini, Gianluca, Giovanardi, Francesco, Rossi, Massimo, Giannini, Edoardo G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365701/
https://www.ncbi.nlm.nih.gov/pubmed/33866547
http://dx.doi.org/10.1111/eci.13575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365701/
https://www.ncbi.nlm.nih.gov/pubmed/33866547
http://dx.doi.org/10.1111/eci.13575

Ejemplares similares